Pharmaceutical contract manufacturing market valued at US $ 188.9

Visiongain has published a new report on Top 50 Contract Manufacturing Pharmaceuticals Organizations Market forecast 2021-2031.

Visiongain’s lead expert says: “The global pharmaceutical contract manufacturing market was valued at US $ 93.0 billion in 2020 and is expected to reach a market value of US $ 188.9 billion by 2031 ”.

Are you in the global race? Where do you stand in the fierce global competition?

Fierce competition, strict regulations, declining research and development, sinking margins, strong pricing pressures, and patent cliffs encompass today’s pharmaceutical industry. It is a well known fact that the future of the pharmaceutical / biopharmaceutical industry depends on innovation, and innovation comes from collaborations or partnerships.

Download a sample exclusive report @

Key questions answered in this report:

  • Detailed analysis and ranking of Top 50 Pharmaceutical Marketing Directors in the world market.
  • Current state of competition in the market, analysis of market strategy, product mapping, recent activities.
  • What is the current size of the total global pharmaceutical contract manufacturing market?
  • How much will this market be worth from 2021 to 2031?
  • How is the pharmaceutical subcontracting market evolving?
  • What is driving and holding back the pharmaceutical contract manufacturing market?
  • What are the most prominent companies, what are their activities and their prospects?
  • What are the main trends that will affect the pharmaceutical outsourcing market between 2021 and 2031?

Bio / Pharmaceutical Manufacturers Move to Strategic Collaboration with Drug Delivery Technology Companies

Rising healthcare costs, the collapse of patents, the highly competitive pharmaceutical market and the need to develop innovative therapies are pushing researchers and market players to seek alternative and new drug delivery technologies. The resulting advanced drug delivery industry plays a major role in shaping the bio / pharmaceutical industry. Companies with proprietary drug delivery technologies are working with drug manufacturers to apply their technologies to existing products to protect themselves from generic versions and to develop more new drugs. Licensing and strategic collaboration business models exist in the drug delivery industry.

Lack of manufacturing and packaging capabilities seen as an opportunity by marketing managers

Many small drug development companies do not have their own manufacturing facilities and packaging capabilities, so they depend on outsourcing vendors for their manufacturing and packaging needs. Halozyme has engaged third parties for the bulk manufacture of recombinant rHuPH20, PEGPH20 and Hylenex. The company has a supply agreement

Get the detailed table of contents @

The companies featured in this report include:

  1. AbbVie Contract Manufacturing
  2. Alkermes plc
  3. Aurobindo Pharma Ltée.
  4. Avid Bioservices Inc.
  5. Baxter Biopharmaceutical Solutions
  6. Bayer AG
  7. Consort Medical plc
  8. Catalent Pharma Solutions Inc.
  9. Lonza SA
  10. Pfizer
  11. Hoffmann-La Roche SA
  12. Abbott Laboratory
  13. Dr Reddy’s Lab
  14. GlaxoSmithKline
  15. Becton Dickinson et Cie
  16. BioMérieux
  17. Siemens Healthineers SA
  18. CSL Limited
  19. Boston scientist
  20. Divi Laboratories Ltd.
  21. Edwards Lifesciences Corp
  22. Nipro Company
  23. Evonik Degussa
  24. Stryker Company
  25. Thermo Fisher Scientific Inc.
  26. AstraZeneca
  27. Bavarian Nordic
  28. Dupont
  29. Eli Lilly and company
  30. Grifols
  31. JNJ
  32. Merck & Co.
  33. Moderna biotechnology company
  34. Sanofi
  35. Teva Pharmaceuticals
  36. VBI
  37. Novo Nordisk
  38. Novavax inc.
  39. Merck KGaA
  40. Novartis AG
  41. Inovio Pharma inc.
  42. Emerging BioSolutions
  43. Gilead Sciences, Inc.
  44. Zhejiang Hisun Pharmaceutical
  45. WuXiAppTec
  46. Huapont Medical
  47. Koninklijke DSM NV (Royal DSM)
  48. McKesson Company
  49. PPD Inc.
  50. Strides

How will this report help you?

The 433-page report provides a clear and detailed overview of pharmaceutical contract manufacturing market. Learn about the top 50 global rankings, key business strategies adopted by key players, product mapping, services provided, recent company activities, key drivers and challenges affecting the market.

Read on to find out how you can exploit future emerging business opportunities in this industry. In this brand new 433-page report, you’ll receive over 400 tables and over 300 figures, all of which are unavailable elsewhere.

Visiongain’s study is aimed at anyone needing business analysis for the pharmaceutical outsourcing market. Here you will find data, trends and forecasts.

Find quantitative and qualitative analyzes with independent predictions. Receive information that only our report contains, stay informed with this valuable business intelligence

To access the data contained in this document, please send an email [email protected]

Information found nowhere else
With our new report title, you’re less likely to fall behind in your knowledge or miss out on opportunities. See how our work could benefit your research, analysis and decisions. The Visiongain study is aimed at anyone needing business analysis for the Best Pharmaceutical CMOs Market and leading companies. There you will find data, trends and forecasts.

Find more research reports on thePharmaceutical industry, please click on the following links:

Do you have custom requirements that we can help you with? Do you need specific information about a specific country, geographic region, market segment or company? Contact us today, we can discuss your needs and see how we can help you: [email protected]

About Visiongain

Visiongain is one of the fastest growing and most innovative independent market information, the company publishes hundreds of market research reports which she adds each year to her vast portfolio. These reports provide in-depth analysis of 18 industries around the world. The reports cover a 10-year forecast, are hundreds of pages long, with in-depth market analysis and valuable competitive intelligence data. Visiongain works across a range of verticals, which can currently influence each other, these markets include automotive, aviation, chemicals, cybersecurity, defense, energy, food and beverage, materials, packaging, pharmaceuticals and utilities. Our customized and syndicated market research reports mean you can have tailor-made market information tailored to your business needs.


Sara peerun
Commercial director
Visiongain Inc.
Phone : + 44 207 549 9987
United States Tel: 00 1 718 682 4567
EU phone: 00 353 1 695 0006
E-mail: [email protected]
The Web:
Follow us: LinkedIn | Twitter

SOURCE Visiongain Limited.

About Margie Peters

Check Also

Will major new FDA legislation include an expedited approval process?

US lawmakers are under pressure this month to decide whether to make reforms to the …

Leave a Reply

Your email address will not be published.